期刊文献+

Rh阴性血型同胞间半相合造血干细胞移植治疗慢性粒细胞白血病临床研究 被引量:1

Clinical investigation on hematopoietic stem cell transplantation with haploidentical sibling donor but Rh negative blood type for patient with CML
下载PDF
导出
摘要 目的总结国内首例Rh阴性血型同胞间半相合造血干细胞移植经验。方法对1例53岁慢性粒细胞白血病慢性期女性患者实施同胞间半相合造血干细胞移植(外周血干细胞加骨髓干细胞混合移植),观察造血重建及移植相关并发症。结果患者ANC>0.5×109/L,PLT>20×109/L的时间分别为+15d,+18d;染色体检查提示有XY染色体;+39d内未观察到急性移植物抗宿主病、肝静脉闭塞病、肝肾功能损伤等移植并发症。结论半相合造血干细胞移植可解决供者来源困难,是治疗慢性粒细胞白血病的有效手段。 Objective To summarize the experience on the first case of hematopoietic stem cell transplantation (HSCT) with haploidentical sibling donor but Rh negative blood type. Methods A 52 years old female patient, with chronic myelogenous leukemia in chronic phase (CML-CP), received mix-HSCT(peripheral blood stem cells and bone marrow stem cells) with haploidentical sibling donor but Rh negative blood type. The hematopoietic reconstitution and complications correlated with HSCT were observed. Results The days for reaching of neutrophil〉0.5×10^9/L and platelet〉20×10^9/L were +15d and +18d, respectively. It was identified that the sex chromosome was XY after transplantation, besides, no complications happended within+39d,including acute graft versus host disease, venous occlusion disease, hepatic and renal function damage, and so on. Conclusion HSCT with haploidentical donor may make up the insufficiency of donors, and it is confirmed to be an effective therapeutic option for CML patients.
出处 《重庆医学》 CAS CSCD 2007年第17期1689-1690,1693,共3页 Chongqing medicine
基金 重庆市医学重点学科建设基金资助项目(2006C028) 第三军医大学新桥医院"1520人才培养工程"基金资助项目(2006)
关键词 RH血型 半相合 造血干细胞移植 慢性粒细胞白血病 Rh blood type haploidentical H SCT CML
  • 相关文献

参考文献6

二级参考文献55

  • 1Elmaagacli AH, gasoghl S, Peceny R etal. Improved disease free survival after transplantation of peripheral blood stem cells as compared with bone marrow from HLA identical unrelated donors in patients with first chronic phase chronic myeloid leukemia. Blood, 2002,99(4):1 130.
  • 2Hansen JA, Cooley TA, Martin PJ etal. Bone marrow transplants from unrelated donors for patients with chronic myeloid leukemia. N Engl JMed, 1998,338:962.
  • 3Craddock C, Szydlo RM, I)azzi F et al. Cytomegalovirus seropositivity adversely influences outcome after T-depleted unrelated donor transplant in patients with chronic myeloid leukaemia: the case for tailored GVHD prophylaxis. Br J Haematol,2001,112: 228.
  • 4Fauser AA, Basara N, Blau IW et al. A comparative study of peripheral blood stem cell vs bone marrow transplantation from unrelated donors(MUD): a single center study. Bone Marrow Transplant , 2000, 26(Suppl 2):S27.
  • 5Goldman J. Chronic myeloid leukemia:current treatment options. Blood,2001,98(7) :2 039.
  • 6Clift RA, Storb R. Bone marrow transplantation for CML: the seattle experience, Bone Marrow Transplant ,1996,17(Suppl 3) :S1.
  • 7Radich J. Transplant approaches for CML. American Society of Hematology Education Program Book. Philadelphia, 2002. 124.
  • 8Copelan EA, Penza SL, Theil KS et al. The influence of early transplantation, age, GVHD prevention regimen, and other factors on outcome of allogeneic transplantation for CML following BuCy. Bone Marrow Transplant, 2000,26(10) :1 037.
  • 9Carreras E, Tomas JF, Sanz G etal. Unrelated donor bone marrow transplantation as treatment for chronic myeloid leukemia: the Spanish experience. The Chronic Myeloid Leukemia Subcommittee of the GETH. Group Espanol de Transplante Hemopoietico. Haematologico.2000.85(5) :530.
  • 10Gratwohl Am Hermans J, Goldman JM et al. Risk assessment for patient with chronic myeloid leukaemia befor allogeneic blood or marrow trausplantation. Lancet, 1998,352:1 087.

共引文献88

同被引文献11

  • 1陈幸华,刘林,孔佩艳,张曦,张怡,彭贤贵,刘红,孙爱华,王武,曾东风,龚奕,王庆余,赵幼渝,李平,李榜霞,陶克辛.非血缘异基因外周血干细胞移植治疗慢性粒细胞白血病的临床研究[J].重庆医学,2005,34(9):1283-1285. 被引量:14
  • 2江倩,黄晓军,刘开彦,陈欢,陈育红,高志勇,陆道培.异基因造血干细胞移植预处理期间凝血系统的亚临床改变[J].中华血液学杂志,2006,27(3):173-177. 被引量:5
  • 3Matutes E. The value of c-kit in the diagnosis of biphenotypic acute leukemia. EGIL(European Group for the Immunological Classification of leukeemias) [J]. Leukemia, 1998,12(2) :2038.
  • 4Downing JR, Shannon KM. Acute leukemia: a pediatric perspective [J]. Cancer Cell, 2002,2 (6) : 437.
  • 5Wu SQ, Kuo J, Chen XR, et al. Translocation (6,14) in childhood acute mixed lineage leukemia [J]. Cancer Gene Cytogen,2003,141 (2) : 178.
  • 6Daser A, Rabbitts TH. The versatile mixed lineage leukaemia gene MLL and its many associations in leukaemogenesis [J]. Semi Cancer Biol, 2005,15 (3) : 175.
  • 7Ball LM, Bernardo ME, Roelofs H, et al. Cotransplantation of ex vivo-expanded mesenehymal stem cells accelerates lymphocyte recovery and may reduce the risk of graft failure in haploidentical hematopoietic stem-cell transplantation [J]. Blood,2007,110(7) : 2764.
  • 8Aggarwal S, Pittinger MF. Human mesenchymal stem cells modulate alloantigen immune cell responses [J]. Blood, 2005,105 (4) : 1815.
  • 9Lu DP, Dong LJ, Wu T, et al. Conditioning including antithymocyte HLA-mismatched/haploidentical blood and marrow transplantation can achieve comparable outcomes with HLA identical sibling transplantation [J].Blood, 2006,107(8) :3065.
  • 10Cutler C, Giri S, Jeyapalan S, et al. Acute and chronic graft versus-host disease after allogeneie peripheral-blood stem-cell and bone marrow transplantation:a metaanalysis [J].J Clin Oncol,2001,19(6):3685.

引证文献1

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部